Position in BDSX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14
+$8 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 40 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BDSX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026FMR LLC holds $13,563,639,948 across 34 Diagnostics & Research names. BDSX ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,776,436 | $5,296,941,583 | |
| 2 | DHR |
Danaher Corp /De/
|
22,534,329 | $4,272,508,776 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
3,456,244 | $596,202,089 | |
| 4 | NTRA |
Natera, Inc.
|
2,554,254 | $510,825,254 | |
| 5 | ICLR |
Icon PLC
|
4,174,006 | $461,895,500 | |
| 6 | GH |
Guardant Health, Inc.
|
4,116,081 | $380,202,399 | |
| 7 | LH |
Labcorp Holdings Inc.
|
1,288,411 | $343,760,937 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,850,127 | $315,520,657 |
All Filings in BDSX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14 | 1 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6 | 1 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7 | 1 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||